Haemoglobin-based oxygen carriers: Indications and future applications

British Journal of Hospital Medicine

Volumn 76, Issue 2, 2015, Pages 78-83

  Njoku, Maty ^a   St Peter, Deidre ^a   Mackenzie, Colin F ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD SUBSTITUTE; HEMOGLOBIN; HEMOGLOBIN GLUTAMER 256; MACROGOL DERIVATIVE; MALEIMIDE DERIVATIVE; MALEIMIDE-POLYETHYLENE GLYCOL-MODIFIED HEMOGLOBIN, MP4; OXYVITA; POLYMERIZED HEMOGLOBIN; POLYNITROXYLATED PEGYLATED HEMOGLOBIN;

ANEMIA; HEMORRHAGE; HUMAN;

ANEMIA; BLOOD SUBSTITUTES; HEMOGLOBINS; HEMORRHAGE; HUMANS; MALEIMIDES; POLYETHYLENE GLYCOLS;

EID: 84922657373     PISSN: 17508460     EISSN: 17597390     Source Type: Journal    
DOI: 10.12968/hmed.2015.76.2.78     Document Type: Conference Paper

References (21)

1. Alayash A (2014) Blood Substitutes: why haven't we been more successful? Trends Biotechnol 177-85 (doi: 10.1016/j. tibtech.2014.02.006)
2. Belcher JD, Young M, Chen C et al (2013) MP4CO, a pegylated haemoglobin saturated with carbon monoxide is a modulator of HO-1, inflammation and vaso-occlusion in transgenic sickle mice. Blood 122:2757-64 (doi: 10.1182/blood-2013-02-486282)
3. Busch MP (2001) Insights into the epidemiology, natural history and pathogenesis of hepatitis C virus infection from studies of infected donors and blood product recipients. Transfus Clin Biol 8(3):200-6
4. Galvagno Jr SM, Mackenzie CF (2013) New and future resuscitation fluids for trauma patients using haemoglobin and hypertonic saline. Anesthesiol Clin 31:1-19 (doi: 10.1016/j. anclin. 2012.10.004)
5. Hébert PC, Wells G, Martin C, Tweeddale M, Marshall J, Blajchman M (1998) A Canadian survey of transfusion practices in critically ill patients. Transfusion Requirements in Critical Care Investigators and the Canadian Critical Care Trials Group. Crit Care Med 26(3):482-7
6. Hladik W, Pellett PE, Hancock J et al (2012) Association between transfusion with human herpesvirus 8 antibody-positive blood and subsequent mortality. J Infect Dis 206:1497-503 (doi: 10.1093/infdis/jis543)
7. Hosgood SA, Van Heurn E, Nicholson ML (2014) Normothermic machine perfusion of the kidney: better conditioning and repair? Transpllnt (doi: 10.1111/tri. 12319)
8. Jahr JS, Mackenzie C, Pearce LB, Pitman A, Greenburg AG (2008) HBOC-201 as an alternative to blood transfusion: efficacy and safety evaluation in a multicenter phase III trial in elective orthopedic surgery. J Trauma 64:1484-97 (doi: 10.1097/TA.0b013e318173a93f)
9. Kim H, Greenburg A, eds (2013) Haemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics. Springer, Heidelberg, New York
10. Lewis CJ, Ross JD (2014) Haemoglobin-based oxygen carriers: An update on their continued potential for military application. J Trauma Acute Care Surg 77 (3 Suppl 2):S216-21 (doi: 10.1097/TA.0000000000000204)
11. Li T, Tyan C, Liu J, Liu J, Hong W (2013) Polymerized Human Placenta Haemoglobin: Organ Protective Effects and Alternative Clinical Uses. In: Kim HW, Green burg AG, eds. Haemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics. Springer, Berlin, Heidelberg, New York: 399-410
12. Moore EE, Moore FA, Fabian TC et al (2009) Human polymerized haemoglobin for the treatment of hemorrhagic shock when blood is unavailable: The USA Multicenter Trial. J Am Coll Surg 208:1-13 (doi: 10.10l6/j.jamcollsurg.2008.09.023)
13. Natanson C, Kern SJ, Lurie P, Banks SM, Wolfe SM (2008) Cell-free haemoglobin-based blood substitutes and risk of myocardial infarction and death. JAMA 299(19):2304-12 (doi: 10.1001/jama.299.19.jrv80007)
14. Ortiz D, Barros M, Yan S, Cabrales P (2014) Resuscitation from hemorrhagic shock using polymerized haemoglobin compared to blood. Am J Emerg Med 32 (3) 248-55 (doi: 10.1016/j. ajem.2013.11.045)
15. Raat NJ, Tabima DM, Specht PA et al (2013) Direct sGC activation bypasses NO scavenging reactions of intravascular free oxyhaemoglobin and limits vasoconstriction. Antioxid Redox Signal 9(18):2232-43 (doi: 10.1089/ars.2013.5181)
16. Shander A, Hofmann A, Gombotz H, Theusinger OM, Spahn DR (2007) Estimating the cost of blood: past, present, and future directions. Best Pract Res Clin Anaesthesiol 21:271-89
17. Silverman TA, Weiskopf RB (2009) Haemoglobin based oxygen carriers: current status and future directions. Anesthesiology 111:946-63 (doi: 10.1111/j. 1537-2995.2009.02356.x)
18. Thuillier R, Dutheil D, Trieu MT, Mallet V, Allain G, Rousselot M (2011) Supplementation with a new therapeutic oxygen carrier reduces chronic fibrosis and organ dysfunction in kidney static preservation. Am J Transplant 11(9):1845-60 (doi: 10.1111/j.1600-6143.2011.03614.x)
19. Van Hemelrijck J, Levien LJ, Veeckman L, Pitman A, Zafirelis Z, Standi T (2014) A safety and efficacy evaluation of haemoglobinbased oxygen carrier HBOC-201 in a randomized, multicenter red blood cell-controlled trial in noncardiac surgery patients. Anesth Analg 119(4):766-76 (doi: 10.1213/ANE.0000000000000305)
20. Wei L, Wu RB, Yang CM, Zheng SY, Yu XY (2011) Cardioprotective effect of a haemoglobin-based oxygen carrier on cold ischemia/reperfusion injury. Cardiology 120(2):73-83 (doi: 10.1159/000333106)
21. Zou S, Musavi F, Notari EP 4th, Fang CT; ARCNET Research Group (2008) Changing age distribution of the blood donor population in the United States. Transfusion 48(2):251-7